Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Clostridioides Difficile Infection Recurrence: later-stage trial registry
2 of 2 indexed Clostridioides Difficile Infection Recurrence trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Clostridioides Difficile Infection Recurrence: 2 US clinical trials tracked, 2 recruiting.
Clostridioides Difficile Infection Recurrence is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Vedanta Biosciences, running 1 of these trials.
Enrollment posture brief
Registry condition clostridioides-difficile-infection-recurrence
OPEN 2 | RECR 100% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Clostridioides Difficile Infection Recurrence lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Clostridioides Difficile Infection Recurrence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Clostridioides Difficile Infection Recurrence is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences
NCT06237452
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Bactolife A/S
NCT07250724
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Clostridioides Difficile Infection Recurrence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Clostridioides Difficile Infection Recurrence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Clostridioides Difficile Infection Recurrence page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Clostridioides Difficile Infection Recurrence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Vedanta Biosciences sponsors the most Clostridioides Difficile Infection Recurrence trials on record, review their full trial history before evaluating a specific study. See Vedanta Biosciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Clostridioides Difficile Infection Recurrence condition card totals 2 registered trials; most-linked intervention VE303; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.